Search results for "OUTCOME"

showing 10 items of 5148 documents

Images in cardiovascular medicine. Anomalous origin and course of the right coronary artery.

2006

Coronary anomalous origin from the wrong aortic sinus has been thought to be a risk factor for ischemia because of acute takeoff from the aorta and flow between the aorta and the pulmonary artery.1–4 A 30-year-old man suddenly died within an hour of waking. His clinical history revealed no evidence of any disease, and the postmortem toxicological examination was negative. Autopsy ruled out violent or natural noncardiac causes of death and revealed an underlying congenital heart disease, which was characterized by a congenital bicuspid aortic valve and an anomalous origin of the right coronary artery just above the median raphe of the anterior cusp

AdultMaleFatal OutcomeCoronary Vessel AnomaliesHumansHearthSettore MED/08 - Anatomia PatologicaPulmonary ArteryHearth; Anomalous Coronary Artery;Settore MED/11 - Malattie Dell'Apparato CardiovascolareCoronary VesselsAortaAnomalous Coronary ArteryCirculation
researchProduct

Rickettsia typhi and Haemophagocytic Syndrome

2017

Appropriate therapy (dexamethasone, cyclosporin, and etoposide) could save the patient in those cases in which the pathogen-direct therapy has not been sufficient by itself to control the disease.

AdultMaleFeverVomiting030231 tropical medicineTime-to-Treatment03 medical and health sciences0302 clinical medicineFatal OutcomeVirologyRickettsia typhiMedicineAnimalsHumansTreatment FailureRickettsia prowazekiiRickettsia typhileishmaniasisLetter to the EditorTransaminasesAgedAged 80 and overbiologybusiness.industryNauseaTyphus Endemic Flea-BorneExanthemaMiddle Agedbiology.organism_classificationVirologyTexasThrombocytopeniaAnti-Bacterial AgentsInfectious Diseases030211 gastroenterology & hepatologyParasitologyFemalebusinessTyphus Epidemic Louse-BorneThe American Journal of Tropical Medicine and Hygiene
researchProduct

Neuropsychological, clinical and cognitive insight predictors of outcome in a first episode psychosis study.

2012

The outcome of first episode psychosis (FEP) is highly variable and difficult to predict. We studied prospectively the impact of poor insight and neuropsychological deficits on outcomes in a longitudinal cohort of 127 FEP patients. Participants were assessed on 5 domains of cognitive function and 2 domains of insight (clinical and cognitive). At 12. months, patients were assessed again for symptom severity and psychosocial function. Regression analyses revealed that cognitive insight (a measure of self-reflectiveness and self-certainty) was the best baseline predictor of overall psychopathology at 12. months whereas executive function performance at admission to the study indicated later se…

AdultMaleFirst episode psychosisPsychosismedicine.medical_specialtyNeuropsychological TestsYoung AdultNeuropsychologyPredictive Value of TestsOutcome Assessment Health CaremedicineHumansYoung adultPsychiatrySettore MED/25 - PsichiatriaBiological PsychiatryPsychiatric Status Rating ScalesPsychopathologyNeuropsychologyCognitionRegression analysismedicine.diseasePsychiatry and Mental healthPsychotic DisordersPredictive value of testsRegression AnalysisFemaleInsightPsychologyCognition DisordersNeurocognitivePsychopathologyClinical psychologyFollow-Up StudiesSchizophrenia research
researchProduct

Fumaric acid ester treatment in cutaneous lupus erythematosus (CLE): a prospective, open-label, phase II pilot study.

2016

Objective The aim of the study was to assess the efficacy and safety of fumaric acid esters (FAEs) in patients with cutaneous lupus erythematosus (CLE). Methods In this 24-week, prospective, open-label, phase II pilot study, 11 patients with CLE, refractory to topical corticosteroids, were included. The primary endpoint of the study was the evaluation of the efficacy of FAEs after 24 weeks of treatment as assessed by the Revised Cutaneous Lupus Disease Area and Severity Index (RCLASI). Results Compared to baseline, significant improvement in the mean total RCLASI activity score and the mean RCLASI activity score for skin lesions was observed in week 12 ( p = 0.002, p = 0.002, respectively) …

AdultMaleFumaric acidmedicine.medical_specialtyColicPilot ProjectsSeverity of Illness IndexDrug Administration Schedule030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRheumatologyFumaratesLupus Erythematosus CutaneousMedicineHumansIn patientProspective Studies030203 arthritis & rheumatologybusiness.industryHeadacheMiddle AgedDermatologyAlternative treatmentClinical trialTreatment OutcomeFumaric Acid EsterschemistryCutaneous Lupus ErythematosusFemaleOpen labelbusinessLupus
researchProduct

Effectiveness of rehabilitation on pain and function in people affected by hemophilia

2021

Introduction: Literature provides unclear evidence of the effectiveness of many physiotherapy interventions on pain intensity, quality of life, and functional ability in hemophilic patients, and suggests that rehabilitation programs should be focused on functional goals and the disability of patients. Aim: The aim of the present study is to present the outcome of a case series of patients with hemophilia in which a rehabilitation program has been carried out on the basis of a specific individual patient’s functional impairment. Methods: Fifty-one patients were enrolled: 32 patients (Rehab Group) received a rehabilitative treatment, 19 patients for different reasons (living far from the hosp…

AdultMaleGeneral MedicineMiddle AgedHemophilia AExercise TherapyTreatment OutcomeMusculoskeletal PainQuality of LifeHumansFemaleRange of Motion ArticularErratumPain Measurementarthritis hemophilia musculoskeletal rehabilitation pain
researchProduct

Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-α therapy

1998

Abstract Background/Aims: So far, there are no reliable parameters that can predict the long-term sustained response to treatment with interferon-α in patients with chronic hepatitis C. In this study, we have developed a semi-quantitative method to determine the viral load per liver cell and have correlated this factor with the outcome of hepatitis C patients treated with interferon-α. Methods: Hepatitis C virus RNA levels were measured in serum, peripheral blood mononuclear cells and liver cells of randomly chosen hepatitis C patients before treatment with interferon-α ( n =37). The number of cells present in the liver biopsies was determined by a polymerase chain reaction-based quantitati…

AdultMaleGenotypeHepatitis C virusmedicine.medical_treatmentHepacivirusmedicine.disease_causePeripheral blood mononuclear cellPredictive Value of TestsHumansMedicineSerotypingInterferon alfaAgedHepatitis ChronicHepatologybusiness.industryLiver cellAge FactorsInterferon-alphaHepatitis CMiddle AgedViral LoadPrognosismedicine.diseaseHepatitis CTreatment OutcomeCytokineLiverImmunologyLeukocytes MononuclearRNA ViralFemaleViral diseasebusinessViral loadmedicine.drugJournal of Hepatology
researchProduct

Poor mothers, unhealthy children: the transmission of health inequalities in the INMA study, Spain

2019

Background The health of pregnant women and their fetuses are especially sensitive to socioeconomic conditions. This study analyzes the impact of maternal socioeconomic status (SES), evaluated by occupation and maternal education level, in preterm births (PTBs) and in small for gestational age (SGA) fetuses, considering the effect of the potential mediating factors on the SES and birth outcomes. Methods A total of 2497 mother/newborn dyads from the INMA-Spain project were studied. We examined maternal occupation and education in relation to PTB and SGA along with covariate data, using logistic regression analysis. Adjusted models for each of the outcome variables in relation to SES indicato…

AdultMaleGerontologyInequalityBody mass index proceduremedia_common.quotation_subjectMothersSocioeconomic factorsWeight Gain03 medical and health sciencesFetus0302 clinical medicinePregnancyRisk FactorsPolitical scienceHumansUnderweight030212 general & internal medicineOccupationsChildmedia_commonHealth disparityEducational status030503 health policy & servicesSmokingInfant NewbornPregnancy OutcomePublic Health Environmental and Occupational HealthInfantBirth outcomeSmall for gestational ageHealth Status DisparitiesPregnancy ComplicationsSocial ClassSpainEducational StatusPremature BirthFemaleChristian ministryPregnant Women0305 other medical scienceHumanitiesMaternal AgeEuropean Journal of Public Health
researchProduct

Clinical efficacy of semiconductor laser application as an adjunct to conventional scaling and root planing.

2005

Background and Objectives: The aim of the in vitro study was to examine the clinical efficacy of semiconductor laser periodontal pocket irradiation as an adjunct to conventional scaling and root planing. Materials and Methods: Twenty-two healthy patients with a need of periodontal treatment (15 women, 7 men, mean age 45.0� 10.8 years) with at least four teeth in all quadrants, were included. All of them underwent a conventional periodontal treatment including scaling and root planing. Using a split mouth design, two randomly chosen quadrants (one upper and the corresponding lower one) were subsequently treated with an 809 nm GaAlAs laser operated at a power output of 1.0 Watt using a 0.6 mm…

AdultMaleGingival and periodontal pocketmedicine.medical_treatmentBleeding on probingDentistryDermatologySensitivity and SpecificityStatistics NonparametricRoot PlaningTooth mobilityScaling and root planingMedicineHumansPeriodontal PocketProspective StudiesLow-Level Light TherapyProspective cohort studySalineProbabilityPeriodontitisbusiness.industryMiddle Agedmedicine.diseaseCombined Modality TherapyTreatment OutcomeClinical attachment lossCase-Control StudiesDental ScalingSurgeryFemalemedicine.symptombusinessFollow-Up StudiesLasers in surgery and medicine
researchProduct

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

2022

AbstractThe STEP 5 trial assessed the efficacy and safety of once-weekly subcutaneous semaglutide 2.4 mg versus placebo (both plus behavioral intervention) for long-term treatment of adults with obesity, or overweight with at least one weight-related comorbidity, without diabetes. The co-primary endpoints were the percentage change in body weight and achievement of weight loss of ≥5% at week 104. Efficacy was assessed among all randomized participants regardless of treatment discontinuation or rescue intervention. From 5 October 2018 to 1 February 2019, 304 participants were randomly assigned to semaglutide 2.4 mg (n = 152) or placebo (n = 152), 92.8% of whom completed the trial (attended t…

AdultMaleGlucagon-Like PeptideHypoglycemic AgentObesidadInvestigación médicaGeneral MedicineMiddle AgedOverweightWeight LoGeneral Biochemistry Genetics and Molecular BiologyTratamiento médicoTreatment OutcomeDouble-Blind MethodDiabetes Mellitus Type 2GlucemiaControl glucémicoFemaleObesitySettore MED/49 - Scienze Tecniche Dietetiche ApplicateHuman
researchProduct

Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients

2016

International audience; In hepatitis B “e” antigen (HBeAg) positive patients with hepatitis B virus (HBV) mono-infection, intensification of nucleos(t)ide analogue treatment with pegylated interferon (PegIFN) could help induce higher HBeAg seroclearance rates. Our aim was to determine the long-term effect of adding PegIFN to tenofovir (TDF)-containing antiretroviral therapy on seroclearance in HBeAg-positive patients co-infected with the human immunodeficiency virus (HIV) and HBV. In this prospective matched cohort study, 46 patients with 1-year PegIFN intensification during TDF-containing antiretroviral therapy (TDF+PegIFN) were matched 1:1 to controls undergoing TDF without PegIFN (TDF) u…

AdultMaleHBsAgmedicine.medical_specialtyCirrhosisTenofovirmedicine.disease_causeAntiviral Agents[ SDV.MP.VIR ] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyGastroenterology03 medical and health sciencesHepatitis B Chronic0302 clinical medicinePegylated interferonVirologyInternal medicinemedicineHumansHepatitis B e AntigensLongitudinal StudiesProspective Studies030212 general & internal medicineTenofovirProspective cohort studyHepatitis B virusHepatologybusiness.industryvirus diseasesMiddle AgedHepatitis Bmedicine.diseasedigestive system diseases3. Good healthTreatment OutcomeInfectious DiseasesHBeAgImmunology[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyFemale030211 gastroenterology & hepatologyInterferonsbusinessmedicine.drug
researchProduct